natgillin/translations-raw huggingface dataset:
Če iz proizvodnje snovi, njene uporabe ali dajanja v promet izhaja nesprejemljivo tveganje za zdravje ljudi ali okolje , ki jo je treba obravnavati v celi Skupnosti, se Priloga XVII spremeni v skladu s postopkom iz člena 132(3) , tako da se sprejmejo nove omejitve ali spremenijo veljavne omejitve iz Priloge XVII za proizvodnjo, uporabo ali dajanje v promet snovi kot take, v pripravkih ali izdelkih v skladu s postopkom iz členov 68 do 72.
When there is an unacceptable risk to human health or the environment , arising from the manufacture, use or placing on the market of substances, which needs to be addressed on a Community-wide basis, Annex XVII shall be amended in accordance with the procedure referred to in Article 132(3) by adopting new restrictions, or amending current restrictions in Annex XVII, for the manufacture, use or placing on the market of substances on their own, in preparations or in articles, pursuant to the procedure set out in Articles 68 to 72.
Vsaka takšna odločitev upošteva socialno-ekonomski vpliv omejitve, vključno z razpoložljivostjo drugih možnosti.
Any such decision shall take into account the socio-economic impact of the restriction, including the availability of alternatives.
Če iz proizvodnje snovi, njene uporabe ali dajanja v promet izhaja nesprejemljivo tveganje za okolje ali zdravje ljudi, vključno z zdravjem ranljivih skupin prebivalstva in državljanov, ki so že zgodaj v mladosti ali neprestano izpostavljeni mešanicam onesnaževal , ki ga je treba obravnavati v celi Skupnosti, se Priloga XVII spremeni v skladu s postopkom iz člena 132(3a) , tako da se sprejmejo nove omejitve ali spremenijo veljavne omejitve iz Priloge XVII za proizvodnjo, uporabo ali dajanje v promet snovi kot take, v pripravkih ali izdelkih v skladu s postopkom iz členov 68 do 72.
When there is an unacceptable risk to the environment or to human health, including that of vulnerable populations and citizens exposed early in life or continuously to mixtures of pollutants , arising from the manufacture, use or placing on the market of substances, which needs to be addressed on a Community-wide basis, Annex XVII shall be amended in accordance with the procedure referred to in Article 132(3a) by adopting new restrictions, or amending current restrictions in Annex XVII, for the manufacture, use or placing on the market of substances on their own, in preparations or in articles, pursuant to the procedure set out in Articles 68 to 72.
Najbolj ranljivi morajo biti izrecno vključeni pri prepoznavanju nesprejemljivih tveganj za zdravje ljudi.
Those must vulnerable should be explicitly included when unacceptable risks to human health are being identified.
S tem se ponovno vloži predlog spremembe 248 Evropskega parlamenta.
This re-tables the Parliament amendment 248.
Za snovi kot take, v pripravku ali v izdelku, ki izpolnjujejo kriterije za razvrstitev kot rakotvorne, mutagene ali strupene za razmnoževanje iz skupine 1 ali 2 in ki bi jih lahko potrošniki uporabili ter za katere je Komisija predlagala omejitve potrošniške uporabe, se Priloga XVII spremeni v skladu s postopkom iz člena 132(3) .
For a substance on its own, in a preparation or in an article which meets the criteria for classification as carcinogenic, mutagenic or toxic to reproduction, category 1 or 2, and could be used by consumers and for which restrictions to consumer use are proposed by the Commission, Annex XVII shall be amended in accordance with the procedure referred to in Article 132(3) .
Členi 68 do 72 se ne uporabljajo.
Articles 68 to 72 shall not apply.
Za snovi kot take, v pripravku ali v izdelku, ki izpolnjujejo kriterije za razvrstitev kot rakotvorne, mutagene ali strupene za razmnoževanje iz skupine 1 ali 2 in ki bi jih lahko potrošniki uporabili ter za katere je Komisija predlagala omejitve potrošniške uporabe, se Priloga XVII spremeni v skladu s postopkom iz člena 132(3a) .
For a substance on its own, in a preparation or in an article which meets the criteria for classification as carcinogenic, mutagenic or toxic to reproduction, category 1 or 2, and could be used by consumers and for which restrictions to consumer use are proposed by the Commission, Annex XVII shall be amended in accordance with the procedure referred to in Article 132(3a) .
Agencija po datumu iz člena 57(1)(c)(i) za snov iz Priloge XIV preuči, ali uporaba te snovi v izdelkih pomeni tveganje za zdravje ljudi ali okolje, ki ni ustrezno nadzorovano.
After the date referred to in Article 57(1)(c) (i) for a substance listed in Annex XIV, the Agency shall consider whether the use of that substance in articles poses a risk to human health or the environment that is not adequately controlled.
Če Agencija meni, da to tveganje ni ustrezno nadzorovano, pripravi dokumentacijo, ki je v skladu z zahtevami iz Priloge XV.
If the Agency considers that the risk is not adequately controlled, it shall prepare a dossier which conforms to the requirements of Annex XV.
Agencija po datumu iz člena 57(1)(c)(ii) za snov iz Priloge XIV preuči, ali uporaba te snovi v izdelkih pomeni tveganje za zdravje ljudi ali okolje, ki ni ustrezno nadzorovano.
After the date referred to in Article 57(1)(c) (ii) for a substance listed in Annex XIV, the Agency shall consider whether the use of that substance in articles poses a risk to human health or the environment that is not adequately controlled.
Ta novi odstavek je dobrodošel, saj zapolni vrzel v sistemu odobritev, tako da za snovi, ki so razlog za zelo veliko zaskrbljenost, omejuje uporabo v izdelkih.
This new paragraph is welcome, as it closes a loophole in the authorisation system via restrictions on the use of substances of very high concern in articles.
To je pomembno za uvožene izdelke, saj zanje ne veljajo odobritve.
This is relevant for import articles, as they are not covered by authorisations.
Vendar pa bi moralo biti mogoče začeti s postopkom omejevanja, ko postane znano, za katere niso bile zahtevane vloge za odobritev, in ne zgolj po datumu poteka.
However, it should be possible to start the restrictions procedure when it is known for which no applications authorisations have been requested, and not only after the sunset date.
Sicer bi začasno veljala dvojna merila: uvoženi izdelki bi lahko vsebovali snovi, ki zbujajo veliko skrb in za izdelke iz EU niso več odobrene.
Otherwise, there would temporarily be a double standard: imported articles could contain substances of very high concern, which are not authorised anymore for EU articles.
ČLEN 72
ARTICLE 72
Če so izpolnjeni pogoji iz člena 67, Komisija pripravi osnutek spremembe Priloge XVII v treh mesecih po prejemu mnenja Odbora za socialno-ekonomsko analizo ali do konca roka, določenega v skladu s členom 70, če ta odbor ne sprejme mnenja, kar nastopi prej.
If the conditions laid down in Article 67 are fulfilled, the Commission shall prepare a draft amendment to Annex XVII, within three months of receipt of the opinion of the Committee for Socio-economic Analysis or by the end of the deadline established under Article 70 if that Committee does not form an opinion, whichever is the earlier.
V primerih, ko se snov že ureja v Prilogi XVII in če so izpolnjeni pogoji iz člena 67, Komisija pripravi osnutek spremembe Priloge XVII v treh mesecih po prejemu mnenja Odbora za socialno-ekonomsko analizo ali do konca roka, določenega v skladu s členom 70, če ta odbor ne sprejme mnenja, kar nastopi prej.
Where a substance is already regulated in Annex XVII, and if the conditions laid down in Article 67 are fulfilled, the Commission shall prepare a draft amendment to Annex XVII, within three months of receipt of the opinion of the Committee for Socio-economic Analysis or by the end of the deadline established under Article 70 if that Committee does not form an opinion, whichever is the earlier.
Če osnutek spremembe odstopa od izvirnega predloga ali če ne upošteva mnenj Agencije, Komisija priloži podrobno utemeljitev razlogov za neskladja.
Where the draft amendment diverges from the original proposal or if it does not take the opinions from the Agency into account, the Commission shall annex a detailed explanation of the reasons for the differences.
Končna odločitev se sprejme v skladu s postopkom iz člena 132(3) .
A final decision shall be taken in accordance with the procedure referred to in Article 132(3) .
Komisija pošlje osnutek spremembe državi članici vsaj 45 dni pred glasovanjem.
The Commission shall send the draft amendment to the Member States at least 45 days before voting.
Končna odločitev se sprejme v skladu s postopkom iz člena 132(3a) .
A final decision shall be taken in accordance with the procedure referred to in Article 132(3a) .
Če snovi še ne ureja Priloga XVII, Komisija v časovnem okviru iz odstavka 1 Evropskemu parlamentu in Svetu predloži predlog za spremembo Priloge XVII.
Where a substance has not been regulated before in Annex XVII, the Commission shall submit a proposal to the European Parliament and the Council to amend Annex XVII within the time limit specified in paragraph 1.
(Predlog spremembe 251 (delno) – prva obravnava)
(Amendment 251 (partially) - first reading)
V veljavni Direktivi 76/769/EGS imata Evropski parlament in Svet vlogo pri sprejemanju odločitev o nekaterih omejitvah za kemikalije, kot so prepoved uporabe ftalatov v nekaterih igračah.
In the current Directive 76/769/EEC the European Parliament and the Council have a role in decisions on certain restrictions of chemicals such as prohibiting the use of phthalates in certain toys.
Namen tega predloga spremembe je ohraniti ta postopek, ne da se še bolj poveča vloga Komisije.
This amendment aims to keep this procedure and not further increase the role of the Commission.
(d) Odbor za socialno-ekonomsko analizo, ki je odgovoren za pripravo mnenja Agencije o vlogah za odobritev, predlogih za omejitve ter o vseh drugih vprašanjih, ki izhajajo iz uporabe te uredbe v zvezi s socialno-ekonomskim vplivom možnih zakonodajnih ukrepov na snovi;
(d) a Committee for Socio-economic Analysis, which shall be responsible for preparing the opinion of the Agency on applications for authorisation, proposals for restrictions, and any other questions that arise from the operation of this Regulation relating to the socio‑economic impact of possible legislative action on substances;
(d) Odbor za socialno-ekonomsko analizo in oceno nadomestnih možnosti , ki je odgovoren za ocenjevanje razpoložljivosti, primernosti in tehnične izvedljivosti nadomestnih snovi, pa tudi za pripravo mnenja Agencije o vlogah za odobritev, predlogih za omejitve ter o vseh drugih vprašanjih, ki izhajajo iz uporabe te uredbe v zvezi s socialno-ekonomskim vplivom možnih zakonodajnih ukrepov na snovi;
(d) a Committee for Socio-economic Analysis and Alternative Assessment , which shall be responsible for evaluating the availability, suitability and technical feasibility of alternatives, preparing the opinion of the Agency on applications for authorisation, proposals for restrictions, and any other questions that arise from the operation of this Regulation relating to the socio‑economic impact of possible legislative action on substances;
(Spremenjen predlog spremembe 255 – prva obravnava)
(Amendment 255 revised - first reading)
Okrepi povezavo med postopkom odobritve in razpoložljivostjo varnejših nadomestnih možnosti, pri čemer uskladi odgovornost odbora z njegovo vlogo pri ocenjevanju nadomestnih možnosti, kot je opredeljena v členu 63(4).
Reinforces the links between the authorisation procedure and the availability of safer alternatives while aligning the responsibility of the Committee with its role in the assessment of the alternatives as defined in article 63(4).
Sprememba imena odbora bo veljala za celotno besedilo uredbe.
The change in the name of the Committee will apply throughout the text of the regulation.
ČLEN 75, ODSTAVEK 1, TOČKA (D A) (novo)
ARTICLE 75, PARAGRAPH 1, POINT (D A) (new)
(da) Odbor za alternativne testne metode, ki je odgovoren za razvoj in izvajanje integrirane strategije za pospešitev razvoja, potrjevanja in pravnega sprejetja metod testiranja brez živali ter za zagotovitev njihove uporabe v postopni preudarni oceni tveganja za izpolnitev zahtev te uredbe.
(da) a Committee for Alternative Test Methods, which shall be responsible for developing and implementing an integrated strategy to speed up the development, validation and legal acceptance of non-animal test methods, and to ensure their use in intelligent stepwise risk assessment to meet the requirements of this Regulation.
Odbor je odgovoren, da alternativnim testnim metodam dodeljuje sredstva, pridobljena z registracijsko pristojbino.
The Committee shall be responsible for allocating funding for alternative test methods provided through the registration fee.
Odbor sestavljajo strokovnjaki iz Evropskega centra za validiranje alternativnih metod, organizacij za dobrobit živali in drugih zainteresiranih strani.
The Committee shall consist of experts from the European Centre for the Validation of Alternative Methods, animal welfare organisations and other relevant stakeholders.
Odbor vsako leto pripravi poročilo, ki ga Agencija predloži Evropskemu parlamentu in Svetu, in sicer o napredku na področju razvoja, potrjevanja in pravnega sprejetja metod testiranja brez živali, uporabe teh metod v postopni preudarni oceni tveganja za izpolnitev zahtev te uredbe ter znesku in razdelitvi sredstev za alternativne testne metode.
Every year the Committee shall produce a report to be presented by the Agency to the European Parliament and the Council on the progress made on the development, validation and legal acceptance of non-animal test methods, the use of such methods in intelligent stepwise risk assessment to meet the requirements of this Regulation, and the amount and distribution of funding for alternative test methods.
(Predlog spremembe 257 – prva obravnava)
(Amendment 257 - first reading)
Povezano s predlogi sprememb uvodne izjave 92.
Linked to amendments of Recital 92.
Cilj te uredbe, spodbujanje testnih strategij, ki ne vključujejo živali, je treba vključiti v pooblastila in delo Agencije, da se zagotovi učinkovito izvajanje uredbe.
The objective of this Regulation to promote non-animal testing should be included in the mandate and work of the Agency to ensure its effective implementation.
Pomanjkanje strateškega načrtovanja in usklajevanja pogosto ovira razvoj, potrjevanje, pravno sprejetje in uporabo alternativnih testnih metod.
The development, validation, legal acceptance and use of alternative test methods is often hampered by a lack of strategic planning and coordination.
Zato mora Agencija imeti odbor, ki ga sestavljajo strokovnjaki s področja alternativnih testnih metod z nalogo razviti in izvajati tako strateško načrtovanje in zagotoviti, da se za preudarno in prilagodljivo oceno tveganj uporabljajo alternativne testne metode, da bi preprečili poskuse na živalih in zmanjšali stroške, kjer je to mogoče.
Therefore the Agency should have a Committee consisting of experts in the field of alternative test methods with the mandate to develop and implement such strategic planning and to ensure that alternative test methods are used in intelligent, flexible risk assessment wherever possible to prevent animal testing and save costs.
Poleg tega mora Odbor dodeliti sredstva za alternativne testne metode in pripraviti letno poročilo o napredku za zagotovitev preglednosti.
The Committee should also allocate funding for alternative test methods and produce a yearly report on the progress made to ensure transparency.
(d) vzpostavitev in vzdrževanje zbirke (zbirk) podatkov z informacijami o vseh registriranih snoveh, popisom razvrstitev in označitev ter usklajenim seznamom razvrstitev in označitev.
(d) establishing and maintaining database(s) with information on all registered substances, the classification and labelling inventory and the harmonised classification and labelling list.
Informacije iz zbirke (zbirk) podatkov, ki je (so) določena(-e) v členu 118(1) in (2), so brezplačno na razpolago javnosti na internetu, razen kadar velja za utemeljenega zahtevek na podlagi člena 10(a)(xi).
It shall make the information identified in Article 118(1) and (2) in the database(s) publicly available, free of charge, over the Internet, except where a request made under Article 10(a)(xi) is considered justified.
Agencija omogoči dostop do drugih informacij iz zbirk podatkov na zahtevo v skladu s členom 117;
The Agency shall make other information in the databases available on request in accordance with Article 117;
Informacije iz zbirke (zbirk) podatkov, ki je (so) določena(-e) v členu 118(1) in (2), so v 15 delovnih dneh brezplačno na razpolago javnosti na internetu, razen kadar velja za utemeljenega zahtevek na podlagi člena 10(a)(xi) in javni interes ni prevladujoč.
It shall make the information identified in Article 118(1) and (2) in the database(s) publicly available, within 15 working days, free of charge, over the Internet, except where a request made under Article 10(a)(xi) is considered justified and not overridden by public interest .
(e) javnosti daje na razpolago informacije o tem, katere snovi se trenutno ocenjujejo ali so bile ocenjene v 90 dneh po tem, ko je Agencija prejela informacije, v skladu s členom 118(1);
(e) making publicly available information as to which substances are being, and have been evaluated within 90 days of receipt of the information at the Agency, in accordance with Article 118(1);
(e) javnosti daje na razpolago informacije o tem, katere snovi se trenutno ocenjujejo ali so bile ocenjene v 15 delovnih dneh po tem, ko je Agencija prejela informacije, v skladu s členom 118(1);
(e) making publicly available information as to which substances are being, and have been evaluated within 15 working days of receipt of the information at the Agency, in accordance with Article 118(1);
V skladu s členom 4(2) Uredbe 1049/2001 o dostopu do dokumentov se dostop do dokumenta lahko zavrne zaradi poslovnih interesov le, če ni prevladujočega javnega interesa.
In line with Article 4(2) of Regulation 1049/2001 on access to documents, the access to a document can only be refused on the basis of commercial interests if there is no overriding public interest.
Zato bi bilo treba omeniti prevladujoči javni interes.
A reference to overriding public interest should therefore be added here.
V skladu z Uredbo 1049/2001 bi moral biti običajni odzivni čas 15 delovnih dni.
According to Regulation 1049/2001, the standard response time should be 15 working days.
ČLEN 76, ODSTAVEK 2, TOČKA (G A) (novo)
ARTICLE 76, PARAGRAPH 2, POINT (G A) (new)
(ga) objava seznama snovi, ki izpolnjujejo merila iz člena 56, na svoji spletni strani, eno leto po začetku veljavnosti te uredbe .
(ga) publishing on its website a list of substances that have been identified as fulfilling the criteria referred to in Article 56, one year after the entry into force of this Regulation.
Ta seznam se redno posodablja;
This list shall be updated periodically;
(Predlog spremembe 263, točka gd – prva obravnava)
(Amendment 263 letter gd - first reading)
Seznam snovi, ki izpolnjujejo merila za odobritev, bi moral postati dostopen javnosti.
The list of substances fulfilling the criteria for authorisation should be made public.
(ma) ustanovitev in vzdrževanje centra odličnosti za obveščanje o tveganju; zagotavljanje centraliziranih, usklajenih sredstev na področju podatkov o varni uporabi kemijskih snovi, pripravkov in izdelkov; pospeševanje izmenjave najboljših praks v sektorju za obveščanje o tveganjih.
(ma) establishing and maintaining a centre of excellence for risk communication; providing centralised, coordinated resources in the area of information on the safe use of chemical substances, preparations and articles; facilitating the sharing of best practice in the risk communication sector.
(Predlog spremembe 263, točka gb) s prve obravnave)
(Amendment 263, point gb) of first reading)
Uspešen predlog spremembe iz prve obravnave, s katerim se poskuša omogočiti potrošnikom varno uporabo snovi, pripravkov in izdelkov, ki vsebujejo kemikalije,
Successful First Reading amendment seeking to enable consumers to use substances, preparations and products containing chemicals safely.
Razvoj ustreznega in skladnega sistema obveščanja, ki temelji na tveganju, bo potrošnikom zagotovil potrebne informacije in nasvete, da bodo lahko uporabljali snovi, pripravke in izdelke, ki vsebujejo kemikalije, varno in učinkovito.
The development of an appropriate and consistent communication system based on risk will provide consumers with the necessary information and advice to enable them to use substances, preparations and products containing chemicals safely and effectively.
ČLEN 76, ODSTAVEK 3, TOČKA C
ARTICLE 76, PARAGRAPH 3, POINT C
(c) na zahtevo Komisije pripravijo mnenje o drugih vidikih, povezanih z varnostjo snovi kot takih, v pripravkih ali izdelkih.
(c) at the Commission’s request, drawing up an opinion on any other aspects concerning the safety of substances on their own, in preparations or in articles.
(c) na zahtevo Komisije ali Evropskega parlamenta pripravijo mnenje o drugih vidikih, povezanih z varnostjo snovi kot takih, v pripravkih ali izdelkih.
(c) at the Commission’s or the European Parliament’s request, drawing up an opinion on any other aspects concerning the safety of substances on their own, in preparations or in articles.
(Predlog spremembe 260, točka f) – prva obravnava)
(Amendment 260 letter f) - first reading)
Tudi Parlament mora imeti pravico, da Agencijo zaprosi za mnenje, kot denimo v primeru Evropske agencije za varnost hrane (EFSA)
Parliament should also have the right to request opinions from the Agency, as it is the case for instance with EFSA.
ČLEN 76, ODSTAVEK 4, TOČKA D
ARTICLE 76, PARAGRAPH 4, POINT D
(d) opredelitev strategij in najboljše prakse izvrševanja;
(d) identifying enforcement strategies, as well as best practice in enforcement;
(d) opredelitev strategij in najboljše prakse izvrševanja , pri čemer zlasti upošteva posebne težave za MSP ;
(d) identifying enforcement strategies, as well as best practice in enforcement , taking particular account of the specific problems for SMEs ;
(Predlog spremembe 262, točka d) – prva obravnava)
(Amendment 262 letter d) - first reading)
MSP je treba nuditi posebno pomoč za izvajanje direktive REACH.
Particular help should be given to SMEs for the enforcement of REACH.
ČLEN 77, PODODSTAVEK 3
ARTICLE 77, SUBPARAGRAPH 3
Sprejme notranja pravila in postopke Agencije.
It shall adopt the internal rules and procedures of the Agency.
Pravila se objavijo.
These rules shall be made public .
Predlog, potreben zavoljo predloga spremembe člena 108.
Amendment necessitated by the amendment to Article 108.
ČLEN 78, ODSTAVEK 1
ARTICLE 78, PARAGRAPH 1
Upravni odbor sestavlja po en predstavnik iz vsake države članice, in največ šest predstavnikov, ki jih imenuje Komisija , ter trije predstavniki zainteresiranih strani, ki nimajo glasovalne pravice.
The Management Board shall be composed of one representative from each Member State and a maximum of six representatives appointed by the Commission , including three individuals from interested parties without voting rights.
Vsaka država članica predlaga člana za upravni odbor.
Each Member State shall nominate a member to the Management Board.
Tako predlagane člane imenuje Svet.
The members thus nominated shall be appointed by the Council.
Upravni odbor sestavljajo po en predstavnik iz vsake države članice, in največ šest predstavnikov, ki jih imenuje Komisija , ter dva predstavnika, ki ju predlaga Evropski parlament.
The Management Board shall be composed of one representative from each Member State , and a maximum of six representatives appointed by the Commission and two representatives nominated by the European Parliament.
Poleg tega Komisija imenuje štiri predstavnike zainteresiranih strani (organizacij industrije in potrošnikov, delavskih in okoljevarstvenih organizacij) kot člane upravnega odbora , ki nimajo glasovalne pravice.
In addition, four representatives of interested parties (industry and consumer, worker and environmental protection organisations) shall be nominated by the Commission as members of the Management Board without voting rights .